Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-24-008886

CEO sold 20,272 shares at $29.84 ($604,876)

  • CEO acquired 66,577 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Shah Gaurav · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-16 Sale : show line 1 in the form −20,272 $29.84 $604,876 554,762 D
2024-02-16 Grant or award : show line 2 in the form +66,577 621,339 D
Open-market sales · 20,272 sh · avg $29.84 · $604,876

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-16 Grant or award : show line 3 in the form Stock Option (Right to Buy) +196,336 196,336 D
Loading xslF345X05/form4.xml…